Hepatitis B surface antigen was adsorbed to insolubilized sialic acid-specific haemagglufinin isolated from the haemolymph of Limulus polyphemus. Treatment of the antigen with Vibrio cholerae neuraminidase (EC 3.2.1.18) resulted in the release of sialic acid and in an increase of the isoelectric point from pH 4"35 (for subtype ad) or 4"9 (for subtype ay) to pH 5"45. De-sialylated antigen had a drastically reduced in vivo life span in rabbit plasma and elicited a higher humoral antibody response than intact antigen (subtype ad). Antigen-stimulated proliferation of Iymphocytes, measured 3 months after immunization, was observed only with cells from rabbits injected with neuraminidasetreated antigen.
INTRODUCTION
Cumulative evidence suggests that sialyl residues of sialoglycoproteins represent discriminatory tags determining the type of interactions between these glycoproteins and other macromolecular structures, and consequently the fate of the glycoproteins in vivo. This conclusion is based on the following independent findings: (a) selective removal of sialyl residues results in accelerated elimination from the circulation of plasma glycoproteins (Morell et al. I968; Morell et al. I97I ; Rogers & Kornfeld, I97I ; Regoeczi, Hatton & Wong, 1974) and erythrocytes (Janeik & Schauer, I974) , and in an increased accumulation of lymphocytes in the liver (Woodruff & Gesner, 1969) ; (b) sialyl residues of the virus glycoprotein play an essential role in initiation of infection with vesicular stomafitis virus (Schloemer & Wagner, I974) and possibly with other viruses containing sialoglycoproteins, and (c) treatment with neuraminidase increased the immunogenicity of some tumour cells (Weiss, 1973 )-Since hepatitis B surface antigen (HBsAg) contains carbohydrates (Bond, 1972; Cawley, 1972; Burrell et al. I973; Neurath, Prince & Lippin, I973) linked to three distinct polypeptides (Chairez et al. 1973) , we wished to establish whether sialyl residues were present in HBsAg, and if so, to determine their biological significance.
METHODS
Purification and determination of HB~Ag. Spherical HBsAg particles approx. 20 nm in diam. were purified from pooled sera of HBsAg-pogitive blood donors by precipitation with polyethylene glycol, followed by chromatography on insolubilized concanavalin A, molecular exclusion chromatography, rate zonal and isopycnic sedimentation as described before (Neurath, Prince & Lippin, I974) . HBsAg was determined by radioimmunoassay (RIA; Ausria-I25, Abbott Laboratories, North Chicago, Illinois) and subtyped by haemagglutination (HA) inhibition (Prince, Brotman & Ikram, 1972) . The amount of HBsAg was expressed in RIA units, defined as the volume in nl of a HBsAg-positive serum, used as a standard, required to obtain the same RIA result as with a test sample. This value was determined from a standard curve relating radioactivity (ct/min) to the dilution of the standard serum in human serum negative for both HBsAg and antibodies to HBsAg (HBsAb). The sensitivity limit of RIA was 8 RIA units, corresponding to approx. IO ng/ml (Ling & Overby, I972) .
Titration of HBsAb and measurement of HBsAg-induced proliferation of lymphocytes.
HBsAb was determined by a RIA-inhibition test in sera of rabbits Io days after intravenous injection of HBsAg. Serial twofold dilutions of the sera in normal rabbit serum were mixed with 20o RIA units of HBsAg and incubated for I h at 37 °C. Then each mixture was tested by RIA. The HBsAb titre was expressed as the serum dilution at which a 5o % reduction of ct/min occurred as compared with ct/min for 2oo RIA units of HBsAg alone.
In vitro stimulation of DNA synthesis in peripheral lymphocytes was measured as described recently (Pellegrino et al. I973) . Twenty-two cultures were used per animal. Each culture contained o. I ml of blood collected from rabbits 3 months after immunization with HBsAg. To IO cultures each were added 30 #g of purified HBsAg; another IO cultures served as controls; the remaining 2 cultures received t #I of phytohaemagglutinin-P (Difco Laboratories, Detroit, Michigan). All cultures were incubated 4 days at 37 °C. Preparation of insolubilized Limulus polyphemus haemagglutinin. The haemolymph from Limulus polyphemus, obtained from the Marine Biological Laboratory, Woods Hole, Massachusetts, was centrifuged in the Spinco rotor no. 3o for 2I h at 3o0oo rev/min. The pellet which contained haemocyanin, the most abundant protein of the haemolymph (Marchalonis & Edelman, ~968) , was discarded; the supernatant fluid containing the haemagglutinin was concentrated fourfold by ultrafiltration and stored frozen at -7o °C. A 6 ml sample, containing 80 mg of protein, was mixed with 6 ml ofo-I M-phosphate buffero.5-M-NaC1, pH 8.o, clarified by centrifuging at 8ooo rev/min for 2o min and mixed with 2 g of CNBr-activated Sepharose 4B (Pharmacia, Uppsala, Sweden) at 24 °C for ~6 h. The gel was washed with ~oo ml of o'I4 M-NaCl-o.oI M-tris, pH 7"2, (TS) and then mixed for 2 h at 24 °C with I M-ethanolamine-o.I M-CaC12, pH 8.o. Finally, the gel was washed with 2oo ml of TS-o. r M-CaC12. Thirty mg of protein were linked per g of Sepharose.
Treatment of HB~Ag with neuraminidase and preparation of [14C]-sialic acid-labelled
HB~Ag. In various experiments 2 to IO mg quantities of HBsAg (subtype ad = HBsAg/ad) in r2 ml of o'I M-acetate-I mM-CaC12, pH 5"5, were mixed with 5oo units of protease-free Vibrio cholerae neuraminidase (Behring Diagnostics, Somerville, New Jersey) and incubated 16 h at 37 °C. Control HBsAg was incubated under the same conditions in the absence of neuraminidase. HBsAg was pelleted by centrifuging at 65 ooo rev/min for 3 h in the Spinco rotor SW65. The supernatant fluid was used for sialic acid determinations (Aminoff, i96i ) and the pellets were resuspended in 6 ml of TS. Two and a half ml samples of the neuraminidase-treated HBsAg were layered on top of 2 ml of 2.8 M-glycerol in TS and re-centrifuged under the conditions given above. To label with [14C]-sialic acid, the pellet was resuspended in 2"5 ml of TS, mixed with 0-8 ml of sialyl transferase, prepared from rabbit liver as described by Hickman et al. (I97O) , with o'4#Ci of cytidine-5'-monophosphate-4, 5,6,7,8,9-[14C] -sialic acid (CMP-[14C]-sialic acid, 217 mCi]mmol; New England Nuclear, Boston, Massachusetts) and incubated for I h at 37 °C. Subsequently, the mixture was layered on top of o'5 ml of 2.8 M-glycerol in TS and centrifuged in the rotor SW65 for 40 min at 40000 rev/min. Labelled HBsAg from the supernatant fluid was pelleted by centrifuging at 65 ooo rev/min for 4 h, resuspended in TS and submitted to 2 successive rate zonal sedimentations under conditions given for Fig. 3 . In addition to neuraminidase-treated HBsAg, intact HBsAg and sialyl transferase alone were also incubated with CMP-[14C]-sialic acid and further processed as described.
lsoelectricfocusing. The LKB 81Ol column (LKB Produkter AB, Bromma, Sweden) was used for isoelectric focusing of untreated and neuraminidase-treated HBsAg[ad (2oo #g) and HBsAg/ay (IO #g) . A 1% (v/v) carrier ampholyte covering the pH range of 3 to IO in a o to 6.8 M-glycerol gradient was used. Two ml samples in 3"4 M-glycerol were applied in the middle of the gradient. Electrofocusing was performed at 300 V for 72 h at 12 °C. Samples of 2 ml each were collected. Their pH was measured with the Radiometer type TTTIC titrator (Radiometer, Copenhagen, Denmark). Samples were diluted Io to 5o-fold in normal serum for RIA assays of HBsAg.
Polyacrylamide gel electrophoresis. Labelled HBsAg or crude sialyl transferase was
pelleted by centrifuging at 65 ooo rev/min for appropriate lengths of time and dissolved in 5o to 2oo #1 of o.I M-sodium phosphate-5 M-urea-o-o87 M-SDS-o.I3 M-mercaptoethanol, pH 7"2, and boiled for 3 min. The samples were electrophoresed in 8 % flat polyacrylamide gels under conditions described by Neurath et al. (I972) , except that the gels contained 5 M-urea. The measurement of radioactivity along the gel and the assignment of mol. wt.
to species with distinct electrophoretic mobilities were performed as before (Neurath et al. 1972 ).
Electron microscopy. The loop drop method (Howatson, I969) was used to count HBsAg particles.
RESULTS

Evidence for sialyl residues in HB~Ag
Affinity chromatography of HBsAg on an adsorbent specific for sialyl residues combined with a RIA for HBsAg was expected to answer the question whether or not such residues were exposed on the surface of HBsAg without having to resort to chemical analyses requiring large quantities of HBsAg. HBsAg/ad was adsorbed on insolubilized Limulus polyphemus agglutinin specific for sialyl residues (Sharon & Lis, I972), and was eluted with a buffer containing sialic acid either under conditions given for Fig. I or more slowly at 4 °C with TS-o-I M-CaC12-o.o35 M-sialic acid. The fraction of HBsAg which did not attach to the column was re-chromatographed. The major portion of HBsAg was again adsorbed to the column, indicating that the antigen preparation did not consist of two kinds of particles, one with exposed sialyl residues, and the other devoid of such residues. These results may be better explained by the establishment at 37 °C of an equilibrium between adsorbed and unadsorbed HBsAg. Spectrophotometric analyses of supernatant fluids after pelleting neuraminidase-treated HBsAg revealed that approx. I "9 ~g of sialic acid were released from Ioo/zg of HBsAg/ad. Treatment with neuraminidase resulted in an increase of the isoelectric point of HBsAg from pH 4"35 (for subtype ad) or 4"9 (for subtype ay) to pH 5"45 (Fig. 2) . The former two values agree with published data for the major portion of HBsAg/ad or ay (Howard & Zuckerman, I973) .
Enzymic transfer of [14C]-sialic acid to HBsAg
Identical amounts of untreated and neuraminidase-treated HBsAg[ad were incubated with sialyl transferase and CMP-[14C]-sialic acid, subsequently purified as described in Methods and centrifuged in a glycerol gradient. Only with treated HBsAg[ad was radioactivity recovered in the gradient fractions containing the antigen, suggesting that sialic acid was transferred to de-sialylated but not to intact HBsAg[ad (Fig. 3) -Comparison of the radioactivity and the number of HBsAg particles in pooled fractions 8 to /o revealed that an average of IOO sialic acid molecules were incorporated into a single HBsAg/ad particle.
To show that [14C]-sialic acid became covalently linked to HBsAg/ad glycoproteins and to identify the sialoglycoprotein(s), labelled HBsAg/ad was dissociated in 5 M-urea-o'I3 Mmercaptoethanol-o'o87 M-SDS and electrophoresed in an 8% polyacrylamide gel. The major part of the radioactivity was recovered in a component with an electrophoretic mobility expected for a polypeptide having a mol. wt. of 26 x io 3 (Fig. 4) , identical with the size of the smaller of the two major (glyco)proteins of HBsAg (Gerin, Holland & Purcell, I97I ; Chairez et al. I973) . The remainder of the radioactivity was detected in regions of the gel in which polypeptides with mol. wt. of 3I to 35 and 45 x ~o ~, respectively, would be recovered. The absolute tool. wt. of the sialoglycoproteins may differ from the values based on calibrating the gel with protein standards because of possible anomalies in the electrophoretic mobility of SDS-glycoprotein complexes in relation to protein-SDS complexes. Tables I and 2 show that: (a) de-sialylated HBsAg/ad induced a higher humoral antibody response than untreated HBsAg/ad, and (b) the proliferation of lymphocytes from the majority of test rabbits immunized with neuraminidase-treated HBsAg[ad was stimulated with intact HBsAg/ad while lymphocytes from animals injected with untreated HBsAg/ad were not stimulated.
Lymphocytes from both groups of rabbits did not differ significantly in their proliferative response to phytohaemagglutinin. ~. Probability that R~ = I, determined from the' t' test of significance between two means for ~ 8 degrees of freedom.
§ Mean ratio of ct/min incorporated into cultures stimulated with phytohaemagglutinin to ct/min of control cultures.
I[ Probability that Rph = I, determined for IO degrees of freedom. ¶ Values calculated for an unimmunized rabbit.
humoral immunological responses to intact and de-sialylated HBsAg become available, the following comments appear pertinent: (I) The reduction of the life span in plasma of sialoglycoproteins caused by de-sialylation appears to be a general phenomenon, although the magnitude of the reduction may depend on the species-specificity of the glycoprotein (Regoeczi et al. I974) . Therefore, the life span of HBsAg in human plasma should also become reduced after de-sialylation. Consequently, the immune response in humans to de-sialylated HBsAg should not be the same as the response to intact HBsAg. (2) The cellmediated immune response appears essential for recovery from hepatitis B and for the final clearance of hepatitis B virus and of HBsAg (Dudley, Fox & Sherlock, I972; Kohler et al. I974) . Since a regression of established turnouts was observed after injecting tumourbearing animals with neuraminidase-treated tumour cells (Simmons & Rios, I973; Weiss, I973) , it cannot be excluded that de-sialylated HBsAg may elicit a cellular immune response in HBsAg carriers and thus lead, under favourable circumstances, to termination of the proliferation of hepatitis B virus and of HBsAg synthesis.
